Biofabricating strong and tunable collagen filaments

Background
The repair and regeneration of load-bearing tissues, such as tendons and ligaments, remain a formidable challenge in orthopedic surgery due to the intricate hierarchical organization and exceptional mechanical demands of these biological structures. Current clinical standards primarily rely on autografts or cadaveric allografts, which are frequently hampered by donor site morbidity, limited supply, and potential immunological complications. While various bioengineering approaches have attempted to utilize collagen—the primary structural protein of the extracellular matrix—existing synthetic and processed collagen constructs often lack the necessary fibrillar alignment and tensile strength to match native physiological performance. Furthermore, traditional fabrication methods struggle to achieve the precise structural refinement and molecular density required to produce ultra-fine, bioactive filaments that can support cellular integration while maintaining the high Young's modulus and ultimate tensile strength characteristic of healthy musculoskeletal tissues.
Technology
Researchers at Stony Brook University developed a biofabrication method that produces collagenous filaments by extruding a concentrated acidic collagen solution into a hypertonic coagulation bath containing a hypertonic poly(ethylene glycol) (PEG) bath, triggering rapid pH neutralization, osmotic water removal, and extreme physical compaction. A precision motion system draws the extruded solution at controlled pulling speeds, utilizing extensional and shearing flows to induce simultaneous coagulation, dehydration, and fibrillar alignment. The process allows for tunable filament diameters ranging from 3 to over 100 microns and creates a hierarchical structure that transitions from an isotropic state to a highly ordered nematic phase while preserving the native d-banding of collagen. These filaments exhibit high mechanical properties, including an ultimate tensile strength of up to 0.64 GPa and a Young’s modulus of 8.9 GPa, providing a biocompatible and bio-instructive scaffold for load-bearing tissue engineering and surgical sutures.
Advantages
- Superior Mechanical Strength
- Ultra-Fine Diameter
- Enhanced Bioactivity
- Scalable and Accessible Manufacturing
Application
- Orthopedic Implants and Grafts
- Advanced Surgical Sutures
- Ophthalmic Tissue Engineering
- Tissue Engineering Scaffolds and Research Models
Inventors
Michael Mak, , Pharmacological Sciences
Licensing Potential
Development partner - Commercial partner - Licensing
Licensing Status
Available
Licensing Contact
Valery Matthys, Licensing Associate, Intellectual Property Partners, valery.matthys@stonybrook.edu,
Patent Status
Patent Application Filed
Stage of Development
Prototype Available
Tech ID
050-9523
